Pharmafile Logo

Australian Flu and the dilemma of naming diseases

During the winter of 2017-2018 not a day passed when the Australian flu was not mentioned by the UK press. The British media turned talking about Australian flu into an epidemic in itself. So named because the main flu strain in the UK that winter was the same as in Australia, stigma was created by branding this flu ‘Australian’, with people travelling abroad labelled as disease carriers, and creating negative connections between the name and the country.

Naming diseases after people, places and animals has been common practice throughout the world for centuries, from the more current examples of Swine flu and Lyme disease to 19th century Hodgkin’s Lymphoma and Parkinsons. In recent times, the potentially damaging consequences of ‘naming’ infectious diseases have been identified, and in 2015 the World Health Organisation (WHO) introduced its ‘Best Practices for the Naming of New Human Infectious Diseases’, which prohibits eponymously naming diseases. The primary reason for this prohibition is to avoid any negative impacts on ‘trade, travel, tourism or animal welfare, and to avoid causing offence to any cultural, social, national, regional, professional or ethnic groups.’

It seems to me that although the original thought behind naming a disease was to honour and immortalise those who discovered the ailment,  the tradition has also led to many cases of naming gone wrong that have incited conflict and distress. For example, in 2009 Egypt ordered the slaughter of their entire pig population (in excess of 300,000) as a precaution against the spread of swine flu, which devastated many farmers. We now know that the name ‘swine flu’ was misleading, to say the least, making the slaughter a completely unnecessary measure as pigs were not only blameless in instigation but are also unable to pass the disease onto humans. Other examples include the damaging 1980s media branding of AIDS disease as GRID (gay-related immune deficiency) and the immense impact on local tourism for locations where diseases have been discovered such as Hendra, Lyme and Ebola.

Despite the WHO guidance, the naming practice continues, with Australians being the latest to be branded by an illness because of the Australian flu. Perhaps the media, with its appetite for a catchy headline, should take some responsibility.

By Olivia R

This content was provided by Say Communications

Company Details

 Latest Content from  Say Communications 

The 7 truths behind successful Healthcare influencer engagement programmes

Pharma companies need to be engaging DOLs in the same way as Key Opinion Leaders (KOLs). But how can companies ensure best practice DOL engagement? Here are Say’s recommended critical...

Say wins Communiqué Awards for corporate influencer campaign based on life hacks

SAY received the top recognition for the ‘Excellence in Corporate Communications’ and ‘Excellence in Engagement Through Social Media/Digital Channels – Under £50,000’ categories with our “Lift Up Your Everyday with...

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment

Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?

Meeting the experts behind the story: How building a bicycle led to a revolution in respiratory health

Hear from Professor Wladyslaw Wygnanski, inventor of a revolutionary respiratory medical device called BiMOD.

How ‘Greenwashing’ accusations could delay the very changes its supporters demand

Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...

The power of influence in transforming women’s health

Over the past four years HRT prescriptions have doubled in the UK, the cause was turbo charged by the action of celebrities and influencers.

The doctor will text you now: Why healthcare providers cannot underestimate the importance of communicating change

Healthcare communication needs to switch from ‘transmit’ to ‘receive’, listening to what patients need and embracing the plethora of communication tools wholeheartedly.

Can tobacco companies really reinvent themselves as healthcare companies?

A surprising move by key player, Phillip Morris, has called attention to the start of a new era for the tobacco industry. But can tobacco companies reinvent themselves as healthcare...

Why you should feel optimistic about the future of healthcare

It has been a difficult year to remain hopeful for those working in the healthcare industry, but there are some reasons to remain optimistic.